Literature DB >> 16998487

An exonic splicing silencer represses spliceosome assembly after ATP-dependent exon recognition.

Amy E House1, Kristen W Lynch.   

Abstract

Precursor messenger RNA splicing is catalyzed by the spliceosome, a macromolecular complex that assembles in a stepwise process. The spliceosome's dynamic nature suggests the potential for regulation at numerous points along the assembly pathway; however, thus far, naturally occurring regulation of splicing has only been found to influence a small subset of spliceosomal intermediates. Here we report that the exonic splicing silencer (ESS1) that represses splicing of PTPRC (encoding CD45) exon 4 does not function by the typical mechanism of inhibiting binding of U1 or U2 small nuclear ribonucleoproteins (snRNPs) to the splice sites. Instead, a U1-, U2- and ATP-dependent complex forms across exon 4 that is required for inhibiting progression to the U4-U6-U5 tri-snRNP-containing B complex. Such inhibition represents a new mechanism for splicing regulation and suggests that regulation can probably occur at many of the transitions along the spliceosome assembly pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998487     DOI: 10.1038/nsmb1149

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  48 in total

1.  First come, first served revisited: factors affecting the same alternative splicing event have different effects on the relative rates of intron removal.

Authors:  Manuel de la Mata; Celina Lafaille; Alberto R Kornblihtt
Journal:  RNA       Date:  2010-03-31       Impact factor: 4.942

Review 2.  The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.

Authors:  Elisabeth Daguenet; Gwendal Dujardin; Juan Valcárcel
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

3.  A U1-U2 snRNP interaction network during intron definition.

Authors:  Wei Shao; Hyun-Soo Kim; Yang Cao; Yong-Zhen Xu; Charles C Query
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

4.  Combinatorial control of signal-induced exon repression by hnRNP L and PSF.

Authors:  Alexis A Melton; Jason Jackson; Jiarong Wang; Kristen W Lynch
Journal:  Mol Cell Biol       Date:  2007-07-30       Impact factor: 4.272

5.  Spliceosome assembly pathways for different types of alternative splicing converge during commitment to splice site pairing in the A complex.

Authors:  Matthew V Kotlajich; Tara L Crabb; Klemens J Hertel
Journal:  Mol Cell Biol       Date:  2008-12-08       Impact factor: 4.272

6.  Multiple and specific mRNA processing targets for the major human hnRNP proteins.

Authors:  Julian P Venables; Chu-Shin Koh; Ulrike Froehlich; Elvy Lapointe; Sonia Couture; Lyna Inkel; Anne Bramard; Eric R Paquet; Valérie Watier; Mathieu Durand; Jean-François Lucier; Julien Gervais-Bird; Karine Tremblay; Panagiotis Prinos; Roscoe Klinck; Sherif Abou Elela; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

7.  Auto- and cross-regulation of the hnRNP L proteins by alternative splicing.

Authors:  Oliver Rossbach; Lee-Hsueh Hung; Silke Schreiner; Inna Grishina; Monika Heiner; Jingyi Hui; Albrecht Bindereif
Journal:  Mol Cell Biol       Date:  2009-01-05       Impact factor: 4.272

8.  Repression of prespliceosome complex formation at two distinct steps by Fox-1/Fox-2 proteins.

Authors:  Hua-Lin Zhou; Hua Lou
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

9.  The sld genetic defect: two intronic CA repeats promote insertion of the subsequent intron and mRNA decay.

Authors:  Biswadip Das; Melanie N Cash; Bently Robinson; Christopher S Kuhns; Lisa R Latchney; Margaret A Fallon; Rosemary W Elliott; Arthur R Hand; David J Culp
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

Review 10.  Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.

Authors:  Mo Chen; James L Manley
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09-23       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.